单选题
Imagine a world where your doctor could help you avoid
sickness, using knowledge of your genes as well as how you live your life. Or
where he would prescribe drugs he knew would work and not have
debilitatingside-effects.
Such a future is arriving faster than most realise: genetic tests are already
widely used to identify patients who will be helped or harmed by certain drugs.
And three years ago, in the face of a torrent of new scientific
data, a number of new companies set themselves up to interpret
this information for customers. Through shop fronts on the internet, anyone
could order a testing kit, spit into a tube and send off their
DNA—with results downloaded privately at home. Already customers can find out
their response to many common medications, such as antivirals
and blood-thinning agents. They can also explore their genetic
likelihood of developing deep-vein thrombosis, skin cancer or
glaucoma. The industry has been subject to
conflicting criticisms. {{U}}On the one hand, it stands accused of offering
information too dangerous to trust to consumers; on the other it is charged with
peddling irrelevant, misleading nonsense.{{/U}} For some rare disorders, such as
Huntington's and Tay-Sachs, genetic information is a diagnosis. But most
diseases are more complicated and involve several genes, or an environmental
component, or both. Someone's chance of getting skin cancer, for example, will
depend on whether he worships the sun as well as on his genes.
{{U}}America's Government Accountability Office (GAO) report also revealed what
the industry has openly admitted for years: that results of disease-prediction
tests from different companies sometimes conflict with one another, because
there is no industry-wide agreement on standard lifetime risks.{{/U}}
Governments hate this sort of anarchy and America's, in
particular, is considering regulation. But three things argue against
wholesale regulation. First, the level of interference needs to
be based on the level of risk a test represents. The government does not need to
be involved if someone decides to trace his ancestry or
discover what type of earwax he has. {{U}}Second, the laws on
fraud should be sufficient to deal with the snake-oil salesmen
who promise to predict, say, whether a child might be a sporting champion. And
third, science is changing very fast.{{/U}} Fairly soon, a customer's whole
genome will be sequenced, not merely the parts thought to be
medically relevant that the testing companies now concentrate on, and he will
then be able to crank the results through open-source interpretation software
downloadable from anywhere on the planet. That will create problems, but the
only way to stop that happening would be to make it illegal for someone to have
his genome sequenced— and nobody is seriously suggesting that illiberal
restriction. Instead, then, of reacting in a
hostile fashion to the trend for people to take genetic tests,
governments should be asking themselves how they can make best use of this new
source of information. Restricting access to tests that inform people about bad
reactions to drugs could do harm. The real question is not who controls access,
but how to minimise the risks and maximise the rewards of a useful
revolution.
单选题
Current genetic tests are able to ______.
A. identify customers'response to common medications
B. diagnose customers' health state in the future
C. judge customers' genetic inclination to some diseases
D. find the cause for some diseases, such as glaucoma